<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-11-24</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-11-24</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>44</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>3</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ“° å…¬ä¼—å·</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
é¦–æ¬¡è¯å®èƒ°è…ºç™Œä¸­å­˜åœ¨â€œç¥ç»å…ƒ-ç™Œç»†èƒå‡æ€§çªè§¦â€ï¼Œå½¢æˆæ­£åé¦ˆå¢å¼ºè‚¿ç˜¤ç¥ç»æµ¸æ¶¦ï¼›æ­ç¤ºè‚ºè…ºç™Œæ—©æœŸèµ·æºäºè‚ºæ³¡ç¥–ç»†èƒï¼ŒIL1B-IL1R1è½´é©±åŠ¨å‰ä½“ç—…å˜è¿›å±•ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- è‚¿ç˜¤ç¥ç»æµ¸æ¶¦ä¸è€è¯æœºåˆ¶ï¼ˆå¦‚æŠ—PD-1æ²»ç–—ï¼‰ã€‚<br />
- è‚¿ç˜¤å¾®ç¯å¢ƒï¼ˆå¦‚ä¸‰çº§æ·‹å·´ç»“æ„ã€è‚¿ç˜¤å…ç–«ï¼‰ã€‚<br />
- ç»†èƒä»£è°¢ä¸ç–¾ç—…ï¼ˆå¦‚ç¥ç»ç‚ç—‡ã€ç³–çš®è´¨æ¿€ç´ æŠ—ç‚ï¼‰ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- ç©ºé—´ä¸å•ç»†èƒæµ‹åºè§£æè‚¿ç˜¤æ¼”è¿›è§„å¾‹ã€‚<br />
- æ•´åˆå¤šç»„å­¦ï¼ˆå¦‚GWASã€MRã€æœºå™¨å­¦ä¹ ï¼‰ä¸å•ç»†èƒæŠ€æœ¯ã€‚</p>
<h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
è‚ é“åŠŸèƒ½éšœç¢é©±åŠ¨è¡°è€ç›¸å…³è®¤çŸ¥è¡°é€€ï¼Œä»¥åŠCAR Tç»†èƒå·¥ç¨‹åŒ–æ–°ç­–ç•¥æå‡æŠ—è‚¿ç˜¤ç–—æ•ˆã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- è‚ é“ç¨³æ€ä¸è®¤çŸ¥åŠŸèƒ½è°ƒæ§<br />
- è‚¿ç˜¤å…ç–«æ²»ç–—ï¼ˆCAR Tç»†èƒã€p38é€šè·¯é˜»æ–­ï¼‰<br />
- å¿ƒè„é‡å¡‘ä¸VEGFAå˜å¼‚å½±å“</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- ç»“åˆRNA-seqã€scRNA-seqã€16S fmtç­‰å¤šç»„å­¦æŠ€æœ¯æ·±å…¥è§£æç”Ÿç‰©è¿‡ç¨‹ã€‚<br />
- CTLA-4ä¸ºåŸºç¡€çš„è‡ªè°ƒæ§å›è·¯ç”¨äºCAR Tç»†èƒå·¥ç¨‹åŒ–ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
é¦–æ¬¡å‘ç°é€šè¿‡è°ƒæ§ç‰¹å®šåˆ†å­ï¼Œå¯è¯±å¯¼å°èƒ¶è´¨ç»†èƒè½¬å˜ä¸ºä¿æŠ¤æ€§çŠ¶æ€ï¼Œæœ‰æ•ˆæŠ‘åˆ¶é˜¿å°”èŒ¨æµ·é»˜ç—…ä¸­çš„è„‘éƒ¨ç‚ç—‡ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ¢ç´¢è°ƒæ§å°èƒ¶è´¨ç»†èƒåŠŸèƒ½ä»¥å¯¹æŠ—é˜¿å°”èŒ¨æµ·é»˜ç—…ã€‚<br />
- è¯†åˆ«å’Œåˆ©ç”¨ç‰¹å®šåˆ†å­ä½œä¸ºæ²»ç–—é¶ç‚¹ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- å‘ç°å°èƒ¶è´¨ç»†èƒçš„â€œéšè—â€ä¿æŠ¤æ¨¡å¼ã€‚<br />
- é¦–æ¬¡åˆ©ç”¨åˆ†å­è°ƒæ§å®ç°è„‘éƒ¨ç‚ç—‡çš„é™é»˜ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“° å…¬ä¼—å· (30æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>çº¿ç²’ä½“ä»£è°¢ä¸ç¥ç»ç‚ç—‡ã€ç¥ç»è¡°è€åŠç¥ç»æ­»äº¡çš„å› æœå…³ç³»</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šNeuronlink<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè¡°è€ã€çº¿ç²’ä½“ã€ç‚ç—‡ã€ä»£è°¢ã€ç¥ç»<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkxODY4NDEwMA==&amp;mid=2247490089&amp;idx=1&amp;sn=e0b4b66f03817ecafd0705a333ac2896" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>Cancer cell | ç©ºé—´ä¸å•ç»†èƒæµ‹åºè§£æè‚ºè…ºç™Œæ¼”è¿›è§„å¾‹ï¼šè‚ºæ³¡ç¥–ç»†èƒä¸ºæ—©æœŸèµ·æºï¼ŒIL1B-IL1R1 è½´é©±åŠ¨å‰ä½“ç—…å˜è¿›å±•</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒå¤©åœ°<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€æµ‹åºã€å•ç»†èƒ<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&amp;mid=2247533808&amp;idx=1&amp;sn=3648e81809554b317d0393bdb76c7f47" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>10æœˆæœ€æ–°26+ç”Ÿä¿¡ï¼Œå¤šç»„å­¦ç©ºé—´å…ç–«è°±åˆ†æç¡®å®šäº†ä¸‰çº§æ·‹å·´ç»“æ„ï¼ˆTLSï¼‰çš„äºšç¾¤å¹¶è¿›è¡Œæ·±å…¥åˆ†æï¼Œå»ºè®®æ”¶è—ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šä¸œæ™“ç”Ÿç‰©<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€æ·‹å·´ã€ç”Ÿä¿¡<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2OTU2MzM2NA==&amp;mid=2247493036&amp;idx=1&amp;sn=81dfc13408a7a73095ab96ba40b69fcf" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>7.7åˆ†1åŒºç”Ÿä¿¡ï¼Œå…¨æ–‡32ä¸ªFigureèšç„¦æœ€æ–°çƒ­ç‚¹ï¼šè‚¿ç˜¤ç¥ç»æµ¸æ¶¦ã€‚å°ç¼–è®¤è¯çš„é«˜è´¨é‡ç”Ÿä¿¡æ–‡ç« ï¼ŒæŠ•ç¨¿åˆ°æ¥æ”¶ä»…ä¸¤ä¸ªå¤šæœˆï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç¥ç»ã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504023&amp;idx=4&amp;sn=b7b674173914c9ec26ad3b13cececcfa" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>é™¢å£«å›¢é˜Ÿåˆšå‘è¡¨åœ¨Cancer Cellï¼Œç»“åˆå•ç»†èƒå’Œç©ºè½¬æ­ç¤ºè‚¿ç˜¤ç¥ç»æµ¸æ¶¦ä¿ƒç™Œæœºåˆ¶ã€‚å¤§çƒ­ç‚¹ä¸å®¹é”™è¿‡ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç¥ç»ã€å•ç»†èƒ<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504023&amp;idx=3&amp;sn=70967c1e6c7833caa905735f4a9f525d" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>Tç»†èƒ | Nat.Genet. | åœ¨åŸä»£äººç±»Tç»†èƒä¸­è¿›è¡Œçš„é—ä¼ å’Œè¡¨è§‚é—ä¼ ç­›é€‰å°†å€™é€‰å› æœæ€§è‡ªèº«å…ç–«å˜å¼‚ä¸Tç»†èƒç½‘ç»œå…³è”èµ·æ¥</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šBioJournal Link<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€Tç»†èƒã€è¡¨è§‚é—ä¼ <br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg5NjgxNjkwOA==&amp;mid=2247503142&amp;idx=2&amp;sn=6cdea2562c6ef4d37fd4f2677f432e75" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>ç»¼è¿° | Brief.Bioinform. | å•ç»†èƒè½¬å½•ç»„ç»†èƒç±»å‹æ³¨é‡Šä¸­è®¡ç®—æ–¹æ³•çš„æ¦‚è¿°</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šBioJournal Link<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šBç»†èƒã€å•ç»†èƒã€è½¬å½•ç»„<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg5NjgxNjkwOA==&amp;mid=2247503142&amp;idx=1&amp;sn=95250a5a4c7dd7319e45a082311c8fc3" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>YTHDF2 é€šè¿‡ DUX-ZSCAN4 åˆ†å­å›è·¯æŠ‘åˆ¶å°é¼ èƒšèƒå¹²ç»†èƒä¸­çš„ 2C æ ·çŠ¶æ€</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šè€ä¿Šä¿Šçš„ç”Ÿä¿¡ç¬”è®°<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTç»†èƒã€é€šè·¯<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkyMTI1MTYxNA==&amp;mid=2247519919&amp;idx=1&amp;sn=a4fe7b465e26708b2ed690e8478728e1" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>48.5åˆ†ï¼Œæ˜Ÿçº§çƒ­ç‚¹ï¼Œåˆšå‘å®ŒCancer cellåˆæ¥ä¸ªNatureï¼Œè‚¿ç˜¤ç¥ç»æµ¸æ¶¦ä¸æŠ— PD-1 æ²»ç–—å“åº”ä¸ä½³ç›¸å…³ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç¥ç»<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504023&amp;idx=2&amp;sn=f653d2f94584b0d71957a8003bd16aea" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>æœ€æ–°Cancer Cellé‡ç£…ï¼Œèƒ°è…ºç™Œä¸­é¦–æ¬¡è¯å®ç¥ç»å…ƒä¸ç™Œç»†èƒé—´å­˜åœ¨ â€œç¥ç»å…ƒ-ç™Œç»†èƒå‡æ€§çªè§¦â€ï¼Œå¹¶å½¢æˆæ­£åé¦ˆå¢å¼ºè‚¿ç˜¤ç¥ç»æµ¸æ¶¦ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç¥ç»<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504023&amp;idx=1&amp;sn=efe73daa0b3b0b60f8223a47e7bf8f55" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 20 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-å…¬ä¼—å·">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (13æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>GSE307834 è‚ é“å†…æ„Ÿå—åŠŸèƒ½éšœç¢å¯¼è‡´ä¸å¹´é¾„ç›¸å…³çš„è®¤çŸ¥èƒ½åŠ›ä¸‹é™ [RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€regex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Timothy Cox ; Ashwarya Devason ; Sydney Mason ; Madhav Subramanian ; Andrea Salvador ; Helene Descamps ; Alan Araujo ; Junwon Kim ; Yixuan Zhu ; Lev Litichevskiy ; Sunhee Jung ; Wondsuk Song ; Adrian Martin ; Nathan Henderson ; Kuei-Pin Huang ; Thao Nguyen ; Wisath Sae-Lee ; Iboro Umana ; Maria Sacta ; Ryan Rahman ; Stephen Wisser ; Andrew Nelson ; Ilona Golynker ; Lenka Dohnalova ; Alana McSween ; Eric Hohmann ; Shaan Patel ; Anna Bub ; Clara Sanchez ; Kevt'her Hoxha ; Lavinia Boccia ; Andrea Wong ; Klaas Bahnsen ; Jihee Kim ; Niklas Blank ; Dina Abbasian ; Clarissa Shoffler ; Christopher Petucci ; Fiona McAllister ; Amber Alhadeff ; Marc Fuccillo ; Colin Hill ; Cholsoon Jang ; Nicholas Betley ; Guillaume de Lartigue ; Virginia Lee ; Maayan Levy ; Christoph ThaissSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusAging is accompanied by declining memory function, necessitating the development of effective countermeasures1. Brain- extrinsic factors influencing cognitive decline, including the intestinal microbiome, have emerged as attractive targets for peripheral interventions2-6, but the underlying mechanisms remain largely unclear. Here, by charting a high-resolution map of microbiome aging and its functional consequences throughout the lifespan of mice, we identify a mechanism whereby age- associated inhibition of gut-brain signalling results in impaired novelty-induced neuronal activation in the hippocampus and loss of memory encoding. Specifically, gut bacteria producing medium-chain fatty acids, such as Parabacteroides goldsteinii, accumulate over the lifespan and drive intestinal myeloid cell inflammation through GPR84 signalling. As a result, the function of afferent gut-innervating vagal neurons is impaired, the interoceptive signal received by the brain is weakened, and hippocampal function declines. We leverage this pathway to define interventions that restore memory in aged mice, such as phage targeting of Parabacteroides, GPR84 inhibition, and restoration of vagal activity. These findings indicate a key role for interoceptive signalling from the gastrointestinal tract in regulating brain aging and suggest that interoceptomimetics that stimulate gut-brain communication may counteract age-associated cognitive decline.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307834" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>GSE310581ï¼šé€šè¿‡åŸºäºCTLA-4çš„è‡ªè°ƒèŠ‚å›è·¯æ”¹é€ çš„CAR Tç»†èƒå®ç°ç©ºé—´æ§åˆ¶çš„å¢å¼ºæŠ—è‚¿ç˜¤ç–—æ•ˆ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€spatially<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Afroditi Katsarou ; George Kladis ; Thomas Baardemans ; Maria ThemeliSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe widespread application of CAR T cell therapy to solid tumors is hindered by antigen expression heterogeneity, on-target off-tumor toxicity, and limited functional persistence of CAR T cells. Next generation engineering strategies aiming to overcome these hurdles rely on multiple antigen-targeting approaches that fail to simultaneously address all the limitations and/or the use of synthetic receptor transcriptional circuits, which suffer from slow activation kinetics. Here, we leveraged the unique trafficking properties of CTLA-4, regulated by a rapid internalization process, to create CTLA-4-based activation-inducible antigen receptors (CAVI-Rs). CAVI-Rs were exclusively expressed on T cells upon activation with remarkably fast on/off kinetics and self-sustainable expression. In in vitro and in vivo models of heterogeneous tumors, CAR+CAVI-R dual-engineered T cells demonstrated enhanced cytotoxicity and tumor-selective, spatially restricted functionality. Additionally, intermittent co-expression of the CAVI-R lead to improved T cell metabolic and transcriptional fitness, resulting in superior expansion, persistence and anti-tumor efficacy. The CAVI-R provides a novel, simple, safe, potent, and fully-human approach to expand CAR T cell applicability while improving anti-tumor outcomes.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310581" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>GSE282768 VEGFA ç»ˆæ­¢å¯†ç å­å˜å¼‚åŠ å‰§å¿ƒè‚Œæ¢—æ­»ä¸­çš„å¿ƒè„é‡å¡‘ [scRNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcardiacã€scRNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zhongxiang Chen ; Min ZhangSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusA sustained dosage of Vascular Endothelial Growth Factor A (VEGFA) is crucial for angiogenesis in both homeostasis and cardiovascular diseases. CUG-initiated alternative translation is a conserved mechanism for producing mature VEGFA. Genetic surveys have identified stop-gained variants predicted to prematurely terminate CUG-initiated translation without affecting ATG-initiated translation. However, the impacts of these variants on the vasculature in steady-state and disease conditions remain unknown. Here, we identified that homozygous mice carrying the stop-gained variant were viable. VEGFA dosage reduced to 70% in the Q150X homeostatic heart, with no significant alteration in cardiac function or vasculature. In the MI model, VEGFA dosage in Q150X was reduced to about 40% within the first-week post-infarction, leading to functional deterioration in the post-MI hearts. Significant changes in cellular composition were observed three days post-MI. In particular, endothelial cells in Q150X diverged into a state that showed higher level of hypoxia stress, an elevated inflammatory response, and increased extracellular matrix secretion. Additionally, we observed an increase of Nppb+ stressed cardiomyocytes in both 3 days post-MI and homeostasis. Finally, pro-inflammatory macrophages, neutrophils, and Cd8+T cells were enriched in the ischemic zone of Q150X hearts. CUG-initiated translation contributes significantly to the production of mature VEGFA in ischemic hearts. VEGFA dosage is critical in determining the cellular microenvironment during ischemic injury.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282768" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>GSE282766 VEGFA ç»ˆæ­¢å¯†ç å­å˜å¼‚åŠ å‰§å¿ƒè‚Œæ¢—æ­»ä¸­çš„å¿ƒè„é‡å¡‘ [RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcardiacã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zhongxiang Chen ; Min ZhangSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusA sustained dosage of Vascular Endothelial Growth Factor A (VEGFA) is crucial for angiogenesis in both homeostasis and cardiovascular diseases. CUG-initiated alternative translation is a conserved mechanism for producing mature VEGFA. Genetic surveys have identified stop-gained variants predicted to prematurely terminate CUG-initiated translation without affecting ATG-initiated translation. However, the impacts of these variants on the vasculature in steady-state and disease conditions remain unknown. Here, we identified that homozygous mice carrying the stop-gained variant were viable. VEGFA dosage reduced to 70% in the Q150X homeostatic heart, with no significant alteration in cardiac function or vasculature. In the MI model, VEGFA dosage in Q150X was reduced to about 40% within the first-week post-infarction, leading to functional deterioration in the post-MI hearts. Significant changes in cellular composition were observed three days post-MI. In particular, endothelial cells in Q150X diverged into a state that showed higher level of hypoxia stress, an elevated inflammatory response, and increased extracellular matrix secretion. Additionally, we observed an increase of Nppb+ stressed cardiomyocytes in both 3 days post-MI and homeostasis. Finally, pro-inflammatory macrophages, neutrophils, and Cd8+T cells were enriched in the ischemic zone of Q150X hearts. CUG-initiated translation contributes significantly to the production of mature VEGFA in ischemic hearts. VEGFA dosage is critical in determining the cellular microenvironment during ischemic injury.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282766" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>GSE282734 p38é˜»æ–­é€†è½¬è½¬ç§»æ€§ä¹³è…ºç™Œä¸­çš„å…ç–«æŠ‘åˆ¶å¾®ç¯å¢ƒ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immune<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Priyanka Rajan ; Andrei V Bakin ; Scott I AbramsSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe study investigated the role of p38Î± in regulating the outcome of the immune-tumor interaction in metastatic breast cancer. Single-cell transcriptomic analysis of the immune-TME showed that pharmacological p38 inhibition (p38i) or tumor-specific inactivation of p38Î± by CRISPR/Cas9 (p38KO) resulted in a less exhausted and more activated CD8+ T cell phenotype. Moreover, the myeloid cells in the TME exhibited reduced expression of immune-suppressive factors and chemotactic receptors. Overall, this study highlights a previously unrecognized p38Î±-driven pathway that promotes an immune suppressive TME and that therapeutic blockade of p38Î± has important implications for improving antitumor immunity and patient outcomes.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282734" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>GSE218749 å°¿å¼ ç´  II æ¿€æ´»æ„Ÿè§‰çš®è‚¤é€šè·¯ä»¥ä¿ƒè¿›ç˜™ç—’å’Œçš®è‚¤ç‚ç—‡</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šinflammationã€pathway<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Hua Yang ; RenKai Zhu ; Wenhao Zhang ; Weiwei Chen ; Xinrong Yan ; Chunxu Shan ; Shanghai Xue ; Ruizhen Wang ; Xiaolong Dai ; Ciara Larkin ; Jiafu Wang ; Jianghui MengSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiens ; Mus musculusIn order to study the effect of UII on the transcription level regulation of itch-related genes in sensory neurons and keratinocytes, and to apply UII in mouse dorsal root ganglion neuronal cells and keratinocytes, the study showed that UII significantly upregulated the expression of various characteristics of atopic dermatitis and itch-related genes, such as Fasl, Mrgprx1, Amy2a3, INHBA, IL36G, STEAP2, etc.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE218749" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>GSE307838 è‚ é“å†…æ„Ÿå—åŠŸèƒ½éšœç¢å¯¼è‡´ä¸å¹´é¾„ç›¸å…³çš„è®¤çŸ¥èƒ½åŠ›ä¸‹é™ [16S fmt]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šregex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Timothy Cox ; Ashwarya Devason ; Sydney Mason ; Madhav Subramanian ; Andrea Salvador ; Helene Descamps ; Alan Araujo ; Junwon Kim ; Yixuan Zhu ; Lev Litichevskiy ; Sunhee Jung ; Wondsuk Song ; Adrian Martin ; Nathan Henderson ; Kuei-Pin Huang ; Thao Nguyen ; Wisath Sae-Lee ; Iboro Umana ; Maria Sacta ; Ryan Rahman ; Stephen Wisser ; Andrew Nelson ; Ilona Golynker ; Lenka Dohnalova ; Alana McSween ; Eric Hohmann ; Shaan Patel ; Anna Bub ; Clara Sanchez ; Kevt'her Hoxha ; Lavinia Boccia ; Andrea Wong ; Klaas Bahnsen ; Jihee Kim ; Niklas Blank ; Dina Abbasian ; Clarissa Shoffler ; Christopher Petucci ; Fiona McAllister ; Amber Alhadeff ; Marc Fuccillo ; Colin Hill ; Cholsoon Jang ; Nicholas Betley ; Guillaume de Lartigue ; Virginia Lee ; Maayan Levy ; Christoph ThaissSeries Type : OtherOrganism : Mus musculusAging is accompanied by declining memory function, necessitating the development of effective countermeasures1. Brain- extrinsic factors influencing cognitive decline, including the intestinal microbiome, have emerged as attractive targets for peripheral interventions2-6, but the underlying mechanisms remain largely unclear. Here, by charting a high-resolution map of microbiome aging and its functional consequences throughout the lifespan of mice, we identify a mechanism whereby age- associated inhibition of gut-brain signalling results in impaired novelty-induced neuronal activation in the hippocampus and loss of memory encoding. Specifically, gut bacteria producing medium-chain fatty acids, such as Parabacteroides goldsteinii, accumulate over the lifespan and drive intestinal myeloid cell inflammation through GPR84 signalling. As a result, the function of afferent gut-innervating vagal neurons is impaired, the interoceptive signal received by the brain is weakened, and hippocampal function declines. We leverage this pathway to define interventions that restore memory in aged mice, such as phage targeting of Parabacteroides, GPR84 inhibition, and restoration of vagal activity. These findings indicate a key role for interoceptive signalling from the gastrointestinal tract in regulating brain aging and suggest that interoceptomimetics that stimulate gut-brain communication may counteract age-associated cognitive decline.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307838" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>GSE307836 è‚ é“å†…æ„Ÿå—åŠŸèƒ½éšœç¢å¯¼è‡´ä¸å¹´é¾„ç›¸å…³çš„è®¤çŸ¥èƒ½åŠ›ä¸‹é™ [åˆä½]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šregex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Timothy Cox ; Ashwarya Devason ; Sydney Mason ; Madhav Subramanian ; Andrea Salvador ; Helene Descamps ; Alan Araujo ; Junwon Kim ; Yixuan Zhu ; Lev Litichevskiy ; Sunhee Jung ; Wondsuk Song ; Adrian Martin ; Nathan Henderson ; Kuei-Pin Huang ; Thao Nguyen ; Wisath Sae-Lee ; Iboro Umana ; Maria Sacta ; Ryan Rahman ; Stephen Wisser ; Andrew Nelson ; Ilona Golynker ; Lenka Dohnalova ; Alana McSween ; Eric Hohmann ; Shaan Patel ; Anna Bub ; Clara Sanchez ; Kevt'her Hoxha ; Lavinia Boccia ; Andrea Wong ; Klaas Bahnsen ; Jihee Kim ; Niklas Blank ; Dina Abbasian ; Clarissa Shoffler ; Christopher Petucci ; Fiona McAllister ; Amber Alhadeff ; Marc Fuccillo ; Colin Hill ; Cholsoon Jang ; Nicholas Betley ; Guillaume de Lartigue ; Virginia Lee ; Maayan Levy ; Christoph ThaissSeries Type : OtherOrganism : Mus musculusAging is accompanied by declining memory function, necessitating the development of effective countermeasures1. Brain- extrinsic factors influencing cognitive decline, including the intestinal microbiome, have emerged as attractive targets for peripheral interventions2-6, but the underlying mechanisms remain largely unclear. Here, by charting a high-resolution map of microbiome aging and its functional consequences throughout the lifespan of mice, we identify a mechanism whereby age- associated inhibition of gut-brain signalling results in impaired novelty-induced neuronal activation in the hippocampus and loss of memory encoding. Specifically, gut bacteria producing medium-chain fatty acids, such as Parabacteroides goldsteinii, accumulate over the lifespan and drive intestinal myeloid cell inflammation through GPR84 signalling. As a result, the function of afferent gut-innervating vagal neurons is impaired, the interoceptive signal received by the brain is weakened, and hippocampal function declines. We leverage this pathway to define interventions that restore memory in aged mice, such as phage targeting of Parabacteroides, GPR84 inhibition, and restoration of vagal activity. These findings indicate a key role for interoceptive signalling from the gastrointestinal tract in regulating brain aging and suggest that interoceptomimetics that stimulate gut-brain communication may counteract age-associated cognitive decline.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307836" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>GSE284566 Bç»†èƒåˆºæ¿€æ”¹å˜äº†éæ´»æ€§XæŸ“è‰²ä½“çš„ç»“æ„å’Œé«˜çº§ç»„ç»‡</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šB cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Isabel Sierra ; Natalie E Toothacre ; Robin H van de Weide ; Claudia D Lovell ; Son C Nguyen ; R J Varnett ; Ashley L Cook ; Han-Seul Ryu ; Sarah Pyfrom ; Harrison Wang ; Daniel Beiting ; Jennifer E Philips-Cremins ; Eric F Joyce ; Montserrat C AngueraSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusX Chromosome Inactivation (XCI) equalizes X-linked gene expression between sexes. B cells exhibit dynamic XCI, with Xist RNA/heterochromatic marks absent on the inactive X (Xi) in naive B cells but returning following mitogenic stimulation. The impact of dynamic XCI on Xi structure and maintenance was previously unknown. Here, we find dosage compensation of the Xi with state-specific XCI escape genes in naive and in vitro activated B cells. Allele-specific OligoPaints indicate similar Xi and Xa territories in B cells that are less compact than in fibroblasts. Allele-specific Hi-C reveals a lack of TAD-like structures on the Xi of naive B cells, and stimulation-induced alterations in TAD-like boundary strength independent of gene expression. Notably, Xist deletion in B cells changes TAD boundaries and large-scale Xi compaction. Altogether, our results uncover B cell-specific Xi plasticity which could underlie sex-biased biological mechanisms.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284566" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>GSE310387 ç”²é…°è‚½å—ä½“2å¯¹è‚ ä¸Šçš®ç¨³æ€çš„è´¡çŒ®</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šregex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Shuting Yu ; Yingying LeSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusTo elucidate the mechanisms involved in maintaining intestinal epithelial homeostasis through formyl peptide receptor 1 (FPR2), small intestinal organoids derived from Fpr2f/f mice were used as an ex vivo model. Transcriptomics were examined via RNA-seq following FPR2 activation with MMK-1.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310387" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 3 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (1æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>éšè—çš„å°èƒ¶è´¨ç»†èƒå¼€å…³æœ‰åŠ©äºä¿æŠ¤å¤§è„‘å…å—é˜¿å°”èŒ¨æµ·é»˜ç—…çš„ä¾µå®³ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šAlzheimer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šScientists discovered that lowering a specific molecule helps microglia switch into a protective state that quiets brain inflammation in Alzheimerâ€™s. A small group of these cells seems to have an outsized ability to keep the brain healthier. When a key signal is removed from them, Alzheimerâ€™s symptoms worsen. This pathway may help explain why some people naturally have reduced Alzheimerâ€™s risk.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/11/251122044335.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>è‚¿ç˜¤</td>
<td>7</td>
</tr>
<tr>
<td>å•ç»†èƒ</td>
<td>6</td>
</tr>
<tr>
<td>Tç»†èƒ</td>
<td>6</td>
</tr>
<tr>
<td>ç¥ç»</td>
<td>6</td>
</tr>
<tr>
<td>å…ç–«</td>
<td>5</td>
</tr>
<tr>
<td>ä»£è°¢</td>
<td>4</td>
</tr>
<tr>
<td>regex:intestin(e</td>
<td>al)</td>
</tr>
<tr>
<td>cancer</td>
<td>3</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>3</td>
</tr>
<tr>
<td>ç”Ÿä¿¡</td>
<td>2</td>
</tr>
<tr>
<td>è½¬å½•ç»„</td>
<td>2</td>
</tr>
<tr>
<td>è‚ é“</td>
<td>2</td>
</tr>
<tr>
<td>cardiac</td>
<td>2</td>
</tr>
<tr>
<td>æµ‹åº</td>
<td>1</td>
</tr>
<tr>
<td>æ·‹å·´</td>
<td>1</td>
</tr>
<tr>
<td>èšç±»</td>
<td>1</td>
</tr>
<tr>
<td>é€šè·¯</td>
<td>1</td>
</tr>
<tr>
<td>è¡°è€</td>
<td>1</td>
</tr>
<tr>
<td>çº¿ç²’ä½“</td>
<td>1</td>
</tr>
<tr>
<td>ç‚ç—‡</td>
<td>1</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-å…¬ä¼—å·"></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (20æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI4ODc5MDI5NA==&amp;mid=2247503555&amp;idx=1&amp;sn=bc8d721c9fd5ad15006a3a302d258f23" target="_blank" rel="noopener noreferrer">CRï¼šå“ˆå°”æ»¨åŒ»ç§‘å¤§å­¦å›¢é˜Ÿå‘ç°ï¼ŒPRMT3æ˜¯éå°ç»†èƒè‚ºç™Œå¯¹æ”¾ç–—å’Œå…ç–«æ²»ç–—è€å—çš„å…³é”®ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&amp;mid=2247547151&amp;idx=1&amp;sn=6ff7e4f9cabdffa658b16ef2ed6a799a" target="_blank" rel="noopener noreferrer">ä»‹ç»ä¸€ä¸ªå•ç»†èƒè½¬å½•ç»„ä¸“å±çš„æ•°æ®åŒ…ï¼šTENxPBMCData</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248746&amp;idx=5&amp;sn=a6ce9b0b1a4fb7aa06cf4481ab3405e2" target="_blank" rel="noopener noreferrer">Immunityé‡ç£…ï¼šæ›¹é›ªæ¶›å›¢é˜Ÿæ­ç¤ºè‚¿ç˜¤å…ç–«æ–°æœºåˆ¶</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248746&amp;idx=3&amp;sn=e65baf90181810dd802c146fbc8a218b" target="_blank" rel="noopener noreferrer">ç™»é¡¶topçº§æœŸåˆŠï¼GWAS+å•ç»†èƒåˆ†æè§£å¯†ç–¾ç—…æœºåˆ¶ï¼Œè¿™æ³¢æ€è·¯å¿…é¡»å­¦ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821441&amp;idx=2&amp;sn=c0a4a878fd0d2b7091900556bedd0a77" target="_blank" rel="noopener noreferrer">åŒæ ·æ˜¯ç ”ç©¶ä»£è°¢ï¼Œä»€ä¹ˆæ ·çš„ä¸»é¢˜èƒ½å‘åˆ°Cell Metabolismï¼Ÿ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5MDk3Mzg4OA==&amp;mid=2247498514&amp;idx=1&amp;sn=b1bdfeac28280905c2ab6b4f23e28b55" target="_blank" rel="noopener noreferrer">åƒä¸‡åˆ«åˆ’èµ°ï¼é€Ÿæ¥å›´è§‚ï¼Œä¸‰åˆ†é’Ÿæ•™ä½ ç”¨MMseq2å¿«é€Ÿèšç±»è›‹ç™½è´¨åºåˆ—å¹¶è¿›è¡Œå¯è§†åŒ–åˆ†æï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247569092&amp;idx=2&amp;sn=3aa2db62d0f64ae6f0c2578669a8fdb5" target="_blank" rel="noopener noreferrer">è‡´æ•¬æ—¶ä»£ä¸¨ä»â€œåˆ‡ä¸å®Œâ€çš„è‚¿ç˜¤ï¼Œåˆ°å¤šæ•°æ‚£è€…è‚¿ç˜¤ç¼©å°æˆ–åœæ­¢ç”Ÿé•¿ï¼æ–°è¯ç ”å‘ä¸ºè¿™ç±»æ‚£è€…å¸¦æ¥æ–°ç”Ÿ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzNzY2NDgyOQ==&amp;mid=2247493364&amp;idx=1&amp;sn=9279f7e9bff384137199a7028d18fe81" target="_blank" rel="noopener noreferrer">ANN2ï¼šç”¨äºå¼‚å¸¸æ£€æµ‹çš„äººå·¥ç¥ç»ç½‘ç»œ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248746&amp;idx=8&amp;sn=c69faa24374995d470bc48f32c9d16b6" target="_blank" rel="noopener noreferrer">ç™»æƒå¨æœŸåˆŠï¼èšç„¦é£Ÿç®¡é³ç™Œç ”ç©¶ï¼šä¸­å›½åŒ»å­¦ç§‘å­¦é™¢è‚¿ç˜¤åŒ»é™¢å›¢é˜Ÿå‘ç°Notchä¿¡å·ä¿ƒè¡€ç®¡ç”Ÿæˆå…³é”®æœºåˆ¶</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248746&amp;idx=7&amp;sn=e10b947c4e8ffb46f8968b8c6ab803ef" target="_blank" rel="noopener noreferrer">è™šæ‹Ÿæ„ŸæŸ“èƒ½è§¦å‘å…ç–«ååº”ï¼Ÿã€Šnature neuroscienceã€‹æ­ç¤ºå¤§è„‘çš„ç¥å¥‡é˜²å¾¡æœºåˆ¶</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248746&amp;idx=4&amp;sn=a6bd289ac2f363ce2a7041270472b15b" target="_blank" rel="noopener noreferrer">åˆ©ç”¨ç”Ÿå­˜é¢„åæ¨¡å‹é¢„æµ‹ç™Œç—‡æ‚£è€…ç»“å±€ï¼šä»æ•°æ®åˆ†æåˆ°æ¨¡å‹è§£è¯»</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248746&amp;idx=1&amp;sn=18181433ced848cbf9d906240c318784" target="_blank" rel="noopener noreferrer">èµï¼ä¸¤ä¸ªæœˆå†…ç§’å‘5.9åˆ†ï¼æ•´åˆMR+æœºå™¨å­¦ä¹ +å•ç»†èƒï¼Œç»å…¸æ€è·¯å®åŠ›åœ¨çº¿ï¼Œå¥½å­¦æ˜“å¤ç°~</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU1OTkyMTE4Mg==&amp;mid=2247488971&amp;idx=1&amp;sn=018a56313f9bd2a30b2225df58ee86b7" target="_blank" rel="noopener noreferrer">ç³–çš®è´¨æ¿€ç´ æŠ—ç‚æ–°æœºåˆ¶ï¼šä»£è°¢é‡ç¼–ç¨‹ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247650564&amp;idx=5&amp;sn=80981fc974af24b3617c6c57e122b52e" target="_blank" rel="noopener noreferrer">æŸ³å¶åˆ€ï¼šä¸Šæµ·é•¿æµ·åŒ»é™¢ CAR-NK çªç ´ï¼ŒåŒæ—¶åŒ»é™¢æ­£å¼æ­ç‰Œæˆç«‹ç»†èƒæ²»ç–—ä¸­å¿ƒ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247650564&amp;idx=2&amp;sn=c19ae6a96c58f75a499e123b99fcc507" target="_blank" rel="noopener noreferrer">ä»ã€Œæ²»ç—…ã€åˆ°ã€Œæ²»æœªç—…ã€ï¼šT ç»†èƒçš„ç³»ç»Ÿæ¿€æ´»ä¸è¶…å‰è¯Šæ–­ä¹‹è·¯</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656510573&amp;idx=3&amp;sn=990e2ba812e0d8d6d5df19f5a8f1d2f0" target="_blank" rel="noopener noreferrer">å…³é”®ä»£è°¢è°ƒèŠ‚å› å­ï¼åŒæµå¤§å­¦é™„å±ä¸œæ–¹åŒ»é™¢å‘æ–‡ï¼šå‘ç°â€œæœ€æ¯’ä¹³è…ºç™Œâ€æ½œåœ¨æ²»ç–—é¶ç‚¹</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656510573&amp;idx=2&amp;sn=e71045ad2f41e697954f769324ddd1e2" target="_blank" rel="noopener noreferrer">ä¿ƒè¿›è€è¯æ–°æœºåˆ¶ï¼ä¸­å—å¤§å­¦ç­‰å•ä½åˆä½œå‘æ–‡ï¼šè‚ºè…ºç™Œæ²»ç–—æ½œåœ¨ç”Ÿç‰©æ ‡å¿—ç‰©æˆ–æ²»ç–—é¶ç‚¹</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656510573&amp;idx=1&amp;sn=598f190f5df07ac77d26c17fe509b8f4" target="_blank" rel="noopener noreferrer">è‚ é“èŒç¾¤å¦‚ä½•å½±å“ç–¾ç—…æ²»ç–—ï¼Ÿæåå©·/é™ˆæ´›å—/å€ªå²³ç¼/æ›¾åµ˜/è´¾ä¼Ÿå¹³å›¢é˜Ÿæ­ç¤ºè‚ é“èŒç¾¤åœ¨æŠ—æ€§æ·€ç²‰å¹²é¢„ç›¸å…³è‚ç—…ç–—æ•ˆå¼‚è´¨æ€§ä¸­çš„æ ¸å¿ƒä½œç”¨</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247790520&amp;idx=3&amp;sn=678fa3fbe452f063dba501a90f635132" target="_blank" rel="noopener noreferrer">ä¸Šæµ·äº¤å¤§æœ€æ–°Cellå­åˆŠï¼šè‚ é“èŒç¾¤å½±å“æŠ—æ€§æ·€ç²‰æ²»ç–—è„‚è‚ªè‚çš„æ•ˆæœ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247790520&amp;idx=2&amp;sn=b07b784eddbaf7e6f83787ec36b488ce" target="_blank" rel="noopener noreferrer">Carl Juneæœ€æ–°è®ºæ–‡ï¼šIL-9ä¿¡å·å¢å¼ºCAR-Tç»†èƒæ²»ç–—å®ä½“ç˜¤æ•ˆæœ</a></li>
</ul>
</div>
</details>

<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (3æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE260742" target="_blank" rel="noopener noreferrer">GSE260742 DOT1L é€šè¿‡ PRC1.1 æ‹®æŠ—ä½œç”¨æä¾›è½¬å½•è®°å¿† [ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE260456" target="_blank" rel="noopener noreferrer">GSE260456 DOT1L é€šè¿‡ PRC1.1 æ‹®æŠ—ä½œç”¨æä¾›è½¬å½•è®°å¿† [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248113" target="_blank" rel="noopener noreferrer">GSE248113 TL1A é©±åŠ¨ ILC ä»‹å¯¼çš„ç²’ç»†èƒç”Ÿæˆå’Œç»“è‚ ç‚ç›¸å…³ç™Œç—‡</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-23 21:33</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>